Literature DB >> 19811376

Mesenchymal cell fate and phenotypes in the pathogenesis of emphysema.

Jeffrey C Horowitz1, Fernando J Martinez, Victor J Thannickal.   

Abstract

Emphysema is characterized by the destruction of alveolar parenchymal tissue and the concordant loss of lung epithelial cells, endothelial cells, and interstitial mesenchymal cells. Key features in the pathobiology of emphysema include inflammation, alveolar epithelial cell injury/apoptosis, and excessive activation of extracellular matrix (ECM) proteases. Mesenchymal cells are versatile connective tissue cells that are critical effectors of wound-repair. The excessive loss of connective tissue and the destruction of alveolar septae in emphysema suggest that the mesenchymal cell reparative response to epithelial injury is impaired. Yet, the mechanisms regulating mesenchymal cell (dys)function in emphysema remain poorly understood. We propose that mesenchymal cell fate, modulated by transforming growth factor beta-1 (TGF-beta1) and the balance of ECM proteases and antiproteases, is a critical determinant of the emphysema phenotype. We examine emphysema in the context of wound-repair responses, with a focus on the regulation of mesenchymal cell fate and phenotype. We discuss the emerging evidence supporting that genetic factors, inflammation and environmental factors, including cigarette smoke itself, collectively impair mesenchymal cell survival and function, thus contributing to the pathogenesis of emphysema.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811376      PMCID: PMC3524525          DOI: 10.1080/15412550902905953

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  116 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1.

Authors:  T Ishii; T Matsuse; H Igarashi; M Masuda; S Teramoto; Y Ouchi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

3.  Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts.

Authors:  Sandra J DiCamillo; Isabel Carreras; Maria V Panchenko; Phillip J Stone; Matthew A Nugent; Judith A Foster; Mikhail P Panchenko
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

4.  Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture.

Authors:  Y K Zhu; X D Liu; C M Sköld; T Umino; H J Wang; J R Spurzem; T Kohyama; R F Ertl; S I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-10       Impact factor: 5.464

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels.

Authors:  Tadashi Kohyama; Xiangde Liu; Fu-Qiang Wen; Yun Kui Zhu; Hangjun Wang; Hui Jung Kim; Hajime Takizawa; Lenora B Cieslinski; Mary S Barnette; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

7.  Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.

Authors:  N Minematsu; H Nakamura; H Tateno; T Nakajima; K Yamaguchi
Journal:  Biochem Biophys Res Commun       Date:  2001-11-23       Impact factor: 3.575

8.  Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Authors:  Richard E K Russell; Sarah V Culpitt; Carmen DeMatos; Louise Donnelly; Michael Smith; John Wiggins; Peter J Barnes
Journal:  Am J Respir Cell Mol Biol       Date:  2002-05       Impact factor: 6.914

9.  Glutathione prevents inhibition of fibroblast-mediated collagen gel contraction by cigarette smoke.

Authors:  Hui Jung Kim; Xiangde Liu; Hangjun Wang; Tadashi Kohyama; Tetsu Kobayashi; Fu-Qiang Wen; Debra J Romberger; Shinji Abe; William MacNee; Irfan Rahman; Stephen I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

10.  Fibroblasts and monocyte macrophages contract and degrade three-dimensional collagen gels in extended co-culture.

Authors:  Y Zhu; C M Sköld; X Liu; H Wang; T Kohyama; F Q Wen; R F Ertl; S I Rennard
Journal:  Respir Res       Date:  2001-09-04
View more
  8 in total

1.  Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.

Authors:  Shijing Jia; Manisha Agarwal; Jibing Yang; Jeffrey C Horowitz; Eric S White; Kevin K Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 6.914

2.  Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation.

Authors:  Qing-qing Wang; Hong-zhen Yang; Han-zhi Liu; Su Mi; Xiao-wei Zhang; Hui-min Yan; Yong-gang Ma; Xiao-xing Wang; Zhuo-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2011-06-27       Impact factor: 6.150

3.  Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.

Authors:  Joel Michalski; Nobuhiro Kanaji; Xiangde Liu; Steve Nogel; Xingqi Wang; Hesham Basma; Masanori Nakanishi; Tadashi Sato; Yoko Gunji; Maha Fahrid; Amy Nelson; Kai-Christian Muller; Olaf Holz; Helgo Magnussen; Klaus F Rabe; Myron L Toews; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-04       Impact factor: 6.914

Review 4.  The pathogenesis of COPD and IPF: distinct horns of the same devil?

Authors:  Marco Chilosi; Venerino Poletti; Andrea Rossi
Journal:  Respir Res       Date:  2012-01-11

5.  Smoking and idiopathic pulmonary fibrosis.

Authors:  Chad K Oh; Lynne A Murray; Nestor A Molfino
Journal:  Pulm Med       Date:  2012-02-19

6.  Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis.

Authors:  Philip J O'Reilly; Qiang Ding; Samia Akthar; Guoqiang Cai; Kristopher R Genschmer; Dhiren F Patel; Patricia L Jackson; Liliana Viera; Mojtaba Roda; Morgan L Locy; Ellen A Bernstein; Clare M Lloyd; Kenneth E Bernstein; Robert J Snelgrove; J Edwin Blalock
Journal:  JCI Insight       Date:  2017-11-16

Review 7.  Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Authors:  Andrea Rossi; Bojana Butorac-Petanjek; Marco Chilosi; Borja G Cosío; Matjaz Flezar; Nikolaos Koulouris; José Marin; Neven Miculinic; Guido Polese; Miroslav Samaržija; Sabina Skrgat; Theodoros Vassilakopoulos; Andrea Vukić-Dugac; Spyridon Zakynthinos; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-29

8.  Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.

Authors:  Jun Ikari; Amy J Nelson; Jannah Obaid; Alvaro Giron-Martinez; Kumiko Ikari; Fumihiko Makino; Shunichiro Iwasawa; Yoko Gunji; Maha Farid; Xingqi Wang; Hesham Basma; Dawn Demeo; Carol Feghali-Bostwick; Olaf Holz; Klaus Rabe; Xiangde Liu; Stephen I Rennard
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.